Rich Nelson

Rich Nelson is currently the Executive Vice President Corporate Development at Vericast, where Rich is responsible for the digital transformation of portfolio companies like Harland Clarke and Valassis. Rich is also the Founder and Managing Director of Nelstone Ventures, focusing on investing in technology companies. As a Board Member and Executive VP Corporate Development at vTv Therapeutics LLC, Rich is involved in the development of treatments for type 1 diabetes. Rich has a background in M&A, corporate development, and strategic planning from companies like The Nielsen Company and IAC/InterActiveCorp. Rich holds a Juris Doctor degree from New York University School of Law and a BBA in Finance from the University of Michigan.